Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,776 | 315,471 | 273,779 | 363,715 | 1,103,816 |
| Marketable Securities | 627,204 | 715,005 | 944,688 | 943,864 | 274,151 |
| Receivables | 205,625 | 216,645 | 249,572 | 226,539 | 256,135 |
| Inventories | 112,958 | 104,994 | 95,167 | 89,809 | 89,033 |
| TOTAL | $1,215,138 | $1,426,237 | $1,615,591 | $1,669,211 | $1,775,302 |
| Non-Current Assets | |||||
| PPE Net | 622,613 | 580,248 | 524,200 | 501,908 | 482,736 |
| Intangibles | 4,404,929 | 4,429,583 | 4,287,493 | 4,331,643 | 4,257,847 |
| Other Non-Current Assets | 247,857 | 248,816 | 227,153 | 221,572 | 218,631 |
| TOTAL | $5,275,399 | $5,258,647 | $5,038,846 | $5,055,123 | $4,959,214 |
| Total Assets | $6,490,537 | $6,684,884 | $6,654,436 | $6,724,334 | $6,734,517 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 314,423 | 314,280 | 314,151 |
| Accounts payable and accrued liabilities | 66,471 | 67,829 | 41,717 | 36,592 | 34,704 |
| Accrued Expenses | 365,916 | 398,556 | 304,714 | 265,997 | 214,143 |
| Other current liabilities | 28,854 | 30,973 | 30,157 | 42,230 | 50,626 |
| TOTAL | $480,952 | $517,068 | $710,231 | $675,698 | $628,914 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 21,438 | 21,740 | 22,041 |
| Other Non-Current Liabilities | 2,751,374 | 2,780,180 | 2,465,177 | 2,467,795 | 2,434,567 |
| TOTAL | $2,751,374 | $2,780,180 | $2,486,615 | $2,489,535 | $2,456,608 |
| Total Liabilities | $3,232,326 | $3,297,248 | $3,196,846 | $3,165,233 | $3,085,522 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 175,945 | 174,117 | 172,319 | 171,949 | 171,551 |
| Common Shares | 1,757 | 1,738 | 1,723 | 1,720 | 1,714 |
| Retained earnings | -2,822,457 | -2,641,520 | -2,420,910 | -2,253,972 | -2,077,060 |
| Other shareholders' equity | -6,647 | -1,443 | 133 | 67 | 364 |
| TOTAL | $3,258,211 | $3,387,636 | $3,457,590 | $3,559,101 | $3,648,995 |
| Total Liabilities And Equity | $6,490,537 | $6,684,884 | $6,654,436 | $6,724,334 | $6,734,517 |